Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Alzheimer's Disease

  Free Subscription

Articles published in Acta Neuropathol

Retrieve available abstracts of 77 articles:
HTML format

Single Articles

    April 2020
  1. DEMAREST TG, Varma VR, Estrada D, Babbar M, et al
    Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
    Acta Neuropathol. 2020 Apr 24. pii: 10.1007/s00401-020-02152.
    PubMed     Abstract available

    February 2020
  2. LIU G, Zhang H, Liu B, Wang T, et al
    rs4147929 variant minor allele increases ABCA7 gene expression and ABCA7 shows increased gene expression in Alzheimer's disease patients compared with controls.
    Acta Neuropathol. 2020 Feb 29. pii: 10.1007/s00401-020-02135.

    Expression of ABCA7 in Alzheimer's disease.
    Acta Neuropathol. 2020 Feb 28. pii: 10.1007/s00401-020-02136.

  4. SHI H, Koronyo Y, Rentsendorj A, Regis GC, et al
    Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
    Acta Neuropathol. 2020 Feb 10. pii: 10.1007/s00401-020-02134.
    PubMed     Abstract available

    January 2020
  5. EVANS CE, Miners JS, Piva G, Willis CL, et al
    ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Acta Neuropathol. 2020 Jan 25. pii: 10.1007/s00401-019-02098.
    PubMed     Abstract available

  6. VAN DER LEE SJ, Conway OJ, Jansen I, Carrasquillo MM, et al
    Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
    Acta Neuropathol. 2020 Jan 18. pii: 10.1007/s00401-019-02107.
    PubMed     Abstract available

  7. SMITH R, Pawlik D, Nilsson CF, Englund E, et al
    [18F]Flortaucipir distinguishes Alzheimer's disease from progressive supranuclear palsy pathology in a mixed-pathology case.
    Acta Neuropathol. 2020 Jan 4. pii: 10.1007/s00401-019-02121.

    December 2019
  8. THIERRY M, Boluda S, Delatour B, Marty S, et al
    Human subiculo-fornico-mamillary system in Alzheimer's disease: Tau seeding by the pillar of the fornix.
    Acta Neuropathol. 2019 Dec 10. pii: 10.1007/s00401-019-02108.
    PubMed     Abstract available

  9. KOPER MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, et al
    Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer's disease.
    Acta Neuropathol. 2019 Dec 4. pii: 10.1007/s00401-019-02103.
    PubMed     Abstract available

    August 2019
  10. SAHA S, Siddiqui SS, Khan N, Verhagen A, et al
    Controversies about the subcellular localization and mechanisms of action of the Alzheimer's disease-protective CD33 splice variant.
    Acta Neuropathol. 2019 Aug 22. pii: 10.1007/s00401-019-02065.

  11. GOMES LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, et al
    Abeta-induced acceleration of Alzheimer-related tau-pathology spreading and its association with prion protein.
    Acta Neuropathol. 2019 Aug 14. pii: 10.1007/s00401-019-02053.
    PubMed     Abstract available

  12. MRDJEN D, Fox EJ, Bukhari SA, Montine KS, et al
    The basis of cellular and regional vulnerability in Alzheimer's disease.
    Acta Neuropathol. 2019 Aug 7. pii: 10.1007/s00401-019-02054.
    PubMed     Abstract available

    July 2019
  13. PROKOP S, Miller KR, Labra SR, Pitkin RM, et al
    Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples.
    Acta Neuropathol. 2019 Jul 26. pii: 10.1007/s00401-019-02048.
    PubMed     Abstract available

  14. SLEEGERS K, Van Broeckhoven C
    Novel Alzheimer's disease risk genes: exhaustive investigation is paramount.
    Acta Neuropathol. 2019 Jul 12. pii: 10.1007/s00401-019-02041.

    June 2019
  15. PETERSEN C, Nolan AL, de Paula Franca Resende E, Miller Z, et al
    Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
    Acta Neuropathol. 2019 Jun 27. pii: 10.1007/s00401-019-02036.
    PubMed     Abstract available

    May 2019
  16. VAN DER LEE SJ, Conway OJ, Jansen I, Carrasquillo MM, et al
    A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
    Acta Neuropathol. 2019 May 27. pii: 10.1007/s00401-019-02026.
    PubMed     Abstract available

    April 2019
  17. BOZA-SERRANO A, Ruiz R, Sanchez-Varo R, Garcia-Revilla J, et al
    Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
    Acta Neuropathol. 2019 Apr 20. pii: 10.1007/s00401-019-02013.
    PubMed     Abstract available

  18. DOURLEN P, Kilinc D, Malmanche N, Chapuis J, et al
    The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
    Acta Neuropathol. 2019 Apr 13. pii: 10.1007/s00401-019-02004.
    PubMed     Abstract available

  19. ESTUS S, Shaw BC, Devanney N, Katsumata Y, et al
    Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.
    Acta Neuropathol. 2019 Apr 4. pii: 10.1007/s00401-019-02000.
    PubMed     Abstract available

    March 2019
  20. CAMPION D, Charbonnier C, Nicolas G
    SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data.
    Acta Neuropathol. 2019 Mar 25. pii: 10.1007/s00401-019-01991.
    PubMed     Abstract available

  21. DE ROECK A, Van Broeckhoven C, Sleegers K
    The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.
    Acta Neuropathol. 2019 Mar 22. pii: 10.1007/s00401-019-01994.
    PubMed     Abstract available

    February 2019
  22. BOURASSA P, Tremblay C, Schneider JA, Bennett DA, et al
    Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
    Acta Neuropathol. 2019 Feb 7. pii: 10.1007/s00401-019-01967.
    PubMed     Abstract available

  23. SEMICK SA, Bharadwaj RA, Collado-Torres L, Tao R, et al
    Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease.
    Acta Neuropathol. 2019 Feb 2. pii: 10.1007/s00401-019-01966.
    PubMed     Abstract available

  24. JOSEPHS KA, Murray ME, Tosakulwong N, Weigand SD, et al
    Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
    Acta Neuropathol. 2019;137:227-238.
    PubMed     Abstract available

  25. NICOLAS G, Veltman JA
    The role of de novo mutations in adult-onset neurodegenerative disorders.
    Acta Neuropathol. 2019;137:183-207.
    PubMed     Abstract available

    January 2019
  26. VERGARA C, Houben S, Suain V, Yilmaz Z, et al
    Amyloid-beta pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
    Acta Neuropathol. 2019 Jan 1. pii: 10.1007/s00401-018-1953.
    PubMed     Abstract available

    December 2018
  27. KRAUS A, Saijo E, Metrick MA 2nd, Newell K, et al
    Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease.
    Acta Neuropathol. 2018 Dec 20. pii: 10.1007/s00401-018-1947.
    PubMed     Abstract available

  28. CICOGNOLA C, Brinkmalm G, Wahlgren J, Portelius E, et al
    Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
    Acta Neuropathol. 2018 Dec 13. pii: 10.1007/s00401-018-1948.
    PubMed     Abstract available

    November 2018
  29. MOLINUEVO JL, Ayton S, Batrla R, Bednar MM, et al
    Current state of Alzheimer's fluid biomarkers.
    Acta Neuropathol. 2018 Nov 28. pii: 10.1007/s00401-018-1932.
    PubMed     Abstract available

    "When sex influences the brain: implications for Alzheimer disease".
    Acta Neuropathol. 2018 Nov 15. pii: 10.1007/s00401-018-1931.

  31. WALTER S, Jumpertz T, Huttenrauch M, Ogorek I, et al
    The metalloprotease ADAMTS4 generates N-truncated Abeta4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.
    Acta Neuropathol. 2018 Nov 13. pii: 10.1007/s00401-018-1929.
    PubMed     Abstract available

  32. BROCE IJ, Tan CH, Fan CC, Jansen I, et al
    Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.
    Acta Neuropathol. 2018 Nov 9. pii: 10.1007/s00401-018-1928.
    PubMed     Abstract available

    October 2018
  33. MORRIS GP, Clark IA, Vissel B
    Questions concerning the role of amyloid-beta in the definition, aetiology and diagnosis of Alzheimer's disease.
    Acta Neuropathol. 2018 Oct 22. pii: 10.1007/s00401-018-1918.
    PubMed     Abstract available

  34. OVEISGHARAN S, Arvanitakis Z, Yu L, Farfel J, et al
    Sex differences in Alzheimer's disease and common neuropathologies of aging.
    Acta Neuropathol. 2018 Oct 17. pii: 10.1007/s00401-018-1920.
    PubMed     Abstract available

  35. FALCON B, Zhang W, Schweighauser M, Murzin AG, et al
    Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold.
    Acta Neuropathol. 2018 Oct 1. pii: 10.1007/s00401-018-1914.
    PubMed     Abstract available

    September 2018
  36. KVARTSBERG H, Lashley T, Murray CE, Brinkmalm G, et al
    The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.
    Acta Neuropathol. 2018 Sep 22. pii: 10.1007/s00401-018-1910.
    PubMed     Abstract available

  37. COURADE JP, Angers R, Mairet-Coello G, Pacico N, et al
    Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau.
    Acta Neuropathol. 2018 Sep 20. pii: 10.1007/s00401-018-1911.
    PubMed     Abstract available

  38. LIESINGER AM, Graff-Radford NR, Duara R, Carter RE, et al
    Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.
    Acta Neuropathol. 2018 Sep 15. pii: 10.1007/s00401-018-1908.
    PubMed     Abstract available

  39. PICKETT EK, Rose J, McCrory C, McKenzie CA, et al
    Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease.
    Acta Neuropathol. 2018 Sep 6. pii: 10.1007/s00401-018-1903.
    PubMed     Abstract available

    August 2018
    Different patterns of hippocampal tau pathology in Alzheimer's disease and PART.
    Acta Neuropathol. 2018 Aug 7. pii: 10.1007/s00401-018-1894.

    July 2018
  41. HEINSEN H, Grinberg LT
    On the origin of tau seeding activity in Alzheimer's disease.
    Acta Neuropathol. 2018 Jul 23. pii: 10.1007/s00401-018-1890.

  42. KHAN SS, LaCroix M, Boyle G, Sherman MA, et al
    Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons.
    Acta Neuropathol. 2018 Jul 11. pii: 10.1007/s00401-018-1886.
    PubMed     Abstract available

  43. DEMING Y, Dumitrescu L, Barnes LL, Thambisetty M, et al
    Sex-specific genetic predictors of Alzheimer's disease biomarkers.
    Acta Neuropathol. 2018 Jul 2. pii: 10.1007/s00401-018-1881.
    PubMed     Abstract available

  44. SARDAR SINHA M, Ansell-Schultz A, Civitelli L, Hildesjo C, et al
    Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers.
    Acta Neuropathol. 2018;136:41-56.
    PubMed     Abstract available

    June 2018
  45. ROBINSON JL, Corrada MM, Kovacs GG, Dominique M, et al
    Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.
    Acta Neuropathol. 2018 Jun 18. pii: 10.1007/s00401-018-1872.
    PubMed     Abstract available

    May 2018
  46. MANN DMA, Davidson YS, Robinson AC, Allen N, et al
    Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
    Acta Neuropathol. 2018 May 16. pii: 10.1007/s00401-018-1866.
    PubMed     Abstract available

  47. KAUFMAN SK, Del Tredici K, Thomas TL, Braak H, et al
    Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Acta Neuropathol. 2018 May 11. pii: 10.1007/s00401-018-1855.
    PubMed     Abstract available

    April 2018
  48. ANDROUIN A, Potier B, Nagerl UV, Cattaert D, et al
    Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model.
    Acta Neuropathol. 2018 Apr 25. pii: 10.1007/s00401-018-1847.
    PubMed     Abstract available

  49. HONG W, Wang Z, Liu W, O'Malley TT, et al
    Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer's disease brain.
    Acta Neuropathol. 2018 Apr 23. pii: 10.1007/s00401-018-1846.
    PubMed     Abstract available

    March 2018
  50. DE ROECK A, Duchateau L, Van Dongen J, Cacace R, et al
    An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease.
    Acta Neuropathol. 2018 Mar 27. pii: 10.1007/s00401-018-1841.
    PubMed     Abstract available

  51. HECHT M, Kramer LM, von Arnim CAF, Otto M, et al
    Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.
    Acta Neuropathol. 2018 Mar 24. pii: 10.1007/s00401-018-1834.
    PubMed     Abstract available

    November 2017
  52. TAN CH, Fan CC, Mormino EC, Sugrue LP, et al
    Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
    Acta Neuropathol. 2017 Nov 24. pii: 10.1007/s00401-017-1789.
    PubMed     Abstract available

    June 2017
  53. MCALEESE KE, Walker L, Graham S, Moya ELJ, et al
    Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.
    Acta Neuropathol. 2017 Jun 21. doi: 10.1007/s00401-017-1738.
    PubMed     Abstract available

  54. LACAMPAGNE A, Liu X, Reiken S, Bussiere R, et al
    Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.
    Acta Neuropathol. 2017 Jun 19. doi: 10.1007/s00401-017-1733.
    PubMed     Abstract available

  55. HAURE-MIRANDE JV, Audrain M, Fanutza T, Kim SH, et al
    Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
    Acta Neuropathol. 2017 Jun 13. doi: 10.1007/s00401-017-1737.
    PubMed     Abstract available

    May 2017
  56. JIN WS, Shen LL, Bu XL, Zhang WW, et al
    Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Acta Neuropathol. 2017 May 5. doi: 10.1007/s00401-017-1721.
    PubMed     Abstract available

  57. PASCUAL G, Wadia JS, Zhu X, Keogh E, et al
    Immunological memory to hyperphosphorylated tau in asymptomatic individuals.
    Acta Neuropathol. 2017;133:767-783.
    PubMed     Abstract available

  58. TAKAHASHI H, Klein ZA, Bhagat SM, Kaufman AC, et al
    Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.
    Acta Neuropathol. 2017;133:785-807.
    PubMed     Abstract available

    April 2017
  59. DE ROECK A, Van den Bossche T, van der Zee J, Verheijen J, et al
    Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.
    Acta Neuropathol. 2017 Apr 27. doi: 10.1007/s00401-017-1714.
    PubMed     Abstract available

    March 2017
  60. DURAN-ANIOTZ C, Cornejo VH, Espinoza S, Ardiles AO, et al
    IRE1 signaling exacerbates Alzheimer's disease pathogenesis.
    Acta Neuropathol. 2017 Mar 24. doi: 10.1007/s00401-017-1694.
    PubMed     Abstract available

  61. SUN M, Bell W, LaClair KD, Ling JP, et al
    Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Acta Neuropathol. 2017 Mar 22. doi: 10.1007/s00401-017-1701.
    PubMed     Abstract available

  62. DRUMMOND E, Nayak S, Faustin A, Pires G, et al
    Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.
    Acta Neuropathol. 2017 Mar 4. doi: 10.1007/s00401-017-1691.
    PubMed     Abstract available

    February 2017
  63. DEMING Y, Li Z, Kapoor M, Harari O, et al
    Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
    Acta Neuropathol. 2017 Feb 28. doi: 10.1007/s00401-017-1685.
    PubMed     Abstract available

    January 2017
  64. ZENG J, Chen L, Wang Z, Chen Q, et al
    Marginal vitamin A deficiency facilitates Alzheimer's pathogenesis.
    Acta Neuropathol. 2017 Jan 27. doi: 10.1007/s00401-017-1669.
    PubMed     Abstract available

  65. FURMAN JL, Vaquer-Alicea J, White CL 3rd, Cairns NJ, et al
    Widespread tau seeding activity at early Braak stages.
    Acta Neuropathol. 2017;133:91-100.
    PubMed     Abstract available

  66. JAN A, Jansonius B, Delaidelli A, Somasekharan SP, et al
    eEF2K inhibition blocks Abeta42 neurotoxicity by promoting an NRF2 antioxidant response.
    Acta Neuropathol. 2017;133:101-119.
    PubMed     Abstract available

    December 2016
  67. DRUMMOND E, Wisniewski T
    Alzheimer's disease: experimental models and reality.
    Acta Neuropathol. 2016 Dec 26. doi: 10.1007/s00401-016-1662.
    PubMed     Abstract available

  68. CHAPUIS J, Flaig A, Grenier-Boley B, Eysert F, et al
    Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.
    Acta Neuropathol. 2016.
    PubMed     Abstract available

    November 2016
  69. RAMOS-MIGUEL A, Sawada K, Jones AA, Thornton AE, et al
    Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.
    Acta Neuropathol. 2016.
    PubMed     Abstract available

    October 2016
  70. LACLAIR KD, Donde A, Ling JP, Jeong YH, et al
    Depletion of TDP-43 decreases fibril and plaque beta-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model.
    Acta Neuropathol. 2016.
    PubMed     Abstract available

  71. KOSS DJ, Jones G, Cranston A, Gardner H, et al
    Soluble pre-fibrillar tau and beta-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Acta Neuropathol. 2016.
    PubMed     Abstract available

  72. SANCHEZ-MEJIAS E, Navarro V, Jimenez S, Sanchez-Mico M, et al
    Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
    Acta Neuropathol. 2016.
    PubMed     Abstract available

    September 2016
  73. HART NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M, et al
    Ocular indicators of Alzheimer's: exploring disease in the retina.
    Acta Neuropathol. 2016.
    PubMed     Abstract available

  74. ANDERSEN OM, Rudolph IM, Willnow TE
    Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease.
    Acta Neuropathol. 2016.
    PubMed     Abstract available

    April 2016
  75. KUMAR S, Wirths O, Stuber K, Wunderlich P, et al
    Phosphorylation of the amyloid beta-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
    Acta Neuropathol. 2016;131:525-37.
    PubMed     Abstract available

    January 2016
  76. EISELE YS, Duyckaerts C
    Propagation of Ass pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Acta Neuropathol. 2016;131:5-25.
    PubMed     Abstract available

  77. MCKEE AC, Cairns NJ, Dickson DW, Folkerth RD, et al
    The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy.
    Acta Neuropathol. 2016;131:75-86.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.